Over the next five years the Sleep Apnea Therapeutics And Diagnostics market will register a 6.8% CAGR in terms of revenue, the global market size will reach USD 1.52 billion by 2027.
The global market for sleep apnea diagnostic devices was valued at USD 299.3 million in 2019 and is predicted to increase at a CAGR of 6.8% between 2020 and 2027. The market is being driven by a high prevalence of obstructive sleep apnea, an increase in cases of comorbidities associated with sleep apnea, and a growing elderly population that is prone to respiratory illnesses. Furthermore, the rising prevalence of comorbidities linked with sleep apnea is driving up diagnostic device use. Obstructive Sleep Apnea (OSA) has also become a financial burden on society due to the vast number of misdiagnosed patients, which results in high collateral losses and public and private management costs. For example, the overall economic impact of undiagnosed sleep apnea is projected to be nearly USD 150 billion. As a result of the growing number of persons suffering from this condition, the need for sleep apnea diagnostic devices has skyrocketed.
The report aspects discussed the profile of the top manufacturers of the global Sleep Apnea Therapeutics And Diagnostics market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Sleep Apnea Therapeutics And Diagnostics Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The Sleep Apnea Therapeutics And Diagnostics Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Philips Respironics, ResMed, Becton, Dickinson and Company (CareFusion), Teleflex, Fisher and Paykel Healthcare and others.
Industry News:
Philips intensifies commitment towards providing affordable Sleep and Respiratory care in India
Reiterating its commitment to ‘Sleep Health’, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced a 'No-cost EMI' 1 offer on its products under the Respironics range of sleep and respiratory solutions. These solutions will assist patients suffering from Chronic Obstructive Pulmonary Disease (COPD), a lung disease with long-term breathing problems and Obstructive Sleep Apnea (OSA), a chronic condition where the patient experiences interrupted breathing during sleep.
Sleep Apnea Therapeutics And Diagnostics Market provides details by vendors, including company total revenue (financials), company overview, market potential, global presence, his business report briefly talks about market performance of each business sector covering growth factors and sales volume. this analysis provides the This Sleep Apnea Therapeutics And Diagnostics Market analysis report provides recent trends, granular level data covering market size and share. It provides all the recent updates about CORONA virus and its impact on world economy and human health. By getting this data, key players can obtain profit making and right business opportunities for future growth. Its further guides to increase the product demand and business expansion.
By Type, it is segmented into
By Applications it is segmented into
With a revenue share of 45.2% in 2019, North America dominated the market. Some of the key factors driving the market growth are the rising incidence of sleep disorders, the growing patient pool suffering from cardiovascular diseases, diabetes, and COPD, as well as technologically advanced healthcare facilities and better reimbursement facilities for such health conditions in the region.
The Sleep Apnea Therapeutics And Diagnostics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Sleep Apnea Therapeutics And Diagnostics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes
|
Report Details |
Forecast Period 2022 to 2027 CAGR |
CAGR of 6.8% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies
|
Philips Respironics, ResMed, Becton, Dickinson and Company (CareFusion), Teleflex, Fisher and Paykel Healthcare
|
Regions Covered
|
|
Countries Covered |
|
Base Year
|
2022 |
Historical Year
|
2017 to 2021 |
Forecast Year
| 2022 to 2027 |
Number of Pages | 263 |
Customization Available
|
Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The Sleep Apnea Therapeutics And Diagnostics Market is studied from 2017 - 2027.
What is the growth rate of Sleep Apnea Therapeutics And Diagnostics Market?
The Sleep Apnea Therapeutics And Diagnostics Market is growing at a CAGR of 6.8% over the next 5 years.
Who are the key players in Sleep Apnea Therapeutics And Diagnostics Market?
Philips Respironics, ResMed, Becton, Dickinson and Company (CareFusion), Teleflex, Fisher and Paykel Healthcare
What region does this Sleep Apnea Therapeutics And Diagnostics Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Sleep Apnea Therapeutics And Diagnostics Market?
Polysomnography (PSG) Devices, Actigraphy Systems, Respiratory Polygraph, Pulse Oximeters, Others
What are the major end-use applications of Sleep Apnea Therapeutics And Diagnostics Market?
Drug Manufacturers, Hospitals and Clinics, Private and Government Research Institutes, Academic Institutes
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.